FKBP8 antibody (AA 1-413)
Quick Overview for FKBP8 antibody (AA 1-413) (ABIN525392)
Target
See all FKBP8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- AA 1-413
- 
                                            Purpose
- Mouse polyclonal antibody raised against a full-length human FKBP8 protein.
- 
                                            Sequence
- MASCAEPSEP SAPLPAGVPP LEDFEVLDGV EDAEGEEEEE EEEEEEDDLS ELPPLEDMGQ PPAEEAEQPG ALAREFLAAM EPEPAPAPAP EEWLDILGNG LLRKKTLVPG PPGSSRPVKG QVVTVHLQTS LENGTRVQEE PELVFTLGDC DVIQALDLSV PLMDVGETAM VTADSKYCYG PQGSRSPYIP PHAALCLEVT LKTAVDGPDL EMLTGQERVA LANRKRECGN AHYQRADFVL AANSYDLAIK AITSSAKVDM TFEEEAQLLQ LKVKCLNNLA ASQLKLDHYR AALRSCSLVL EHQPDNIKAL FRKGKVLAQQ GEYSEAIPIL RAALKLEPSN KTIHAELSKL VKKHAAQRST ETALYRKMLG NPSRLPAKCP GKGAWSIPWK WLFGATAVAL GGVALSVVIA ARN
- 
                                            Cross-Reactivity
- Human
- 
                                            Characteristics
- Antibody reactive against mammalian transfected lysate.
- 
                                            Immunogen
- FKBP8 (NP_036313.3, 1 a.a. ~ 413 a.a) full-length human protein.
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working dilution should be determined by the investigator.
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Buffer
- In 1x PBS, pH 7.4
- 
                                            Handling Advice
- Aliquot to avoid repeated freezing and thawing.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
- 
                                            
- 
    
- 
                    
 
                                     
                                     
                                    